Difference between revisions of "FDG-PET Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
Line 22: Line 22:
  
 
*[[Media:Boellaard-Aanbevelingen NEDPAS 2007 - EN- 17032009.pdf|NL Standardization Protocol for Quantitative FDG-PET in multi-Center Trials - Dr Ronald Boellaard]]
 
*[[Media:Boellaard-Aanbevelingen NEDPAS 2007 - EN- 17032009.pdf|NL Standardization Protocol for Quantitative FDG-PET in multi-Center Trials - Dr Ronald Boellaard]]
 +
 +
*The Netherlands Standardization Protocol for Quantitative FDG-PET in Multi-center Trials (English translation of Version 1)
 +
 +
Please keep the following in mind:
 +
 +
The development of this protocol was started about 4 years ago (2005) and approved more than 1 year ago in The Netherlands (NL). However, with gained insight, changed are scheduled to be incorporated in the next version by 2010. The following changes will be made (consider them being applied already or underway):
 +
 +
1. Use of oral contrast is now excluded but will be allowed in the next version
 +
2. We are currently working on standards for CT as well, including GL for doing CT-QC (in cooperation with the radiologists/radiology societies in NL)
 +
3. There will be an upper limit for dosage
 +
4. We are working on traceable/calibrated and mutually linked sources for both PET and the dose calibrator and these will be used for absolute (rather than cross-) calibration (but in addition to the cross-calibration using FDG).
 +
5. Various other minor edits/typos/changes
 +
 +
NB The protocol is not a step-by-step description of the logistics for doing a PET/CT study. However, it has been set up in a somewhat chronological order and may thus be used to populate (copy-paste) such a step-by-step description. Additional work required ... FDG-PET/CT Technical Committee input is highly appreciated.
 +
 +
Kindly submitted by Ronald Boellaard, PhD
  
 
==Slide Presentations==
 
==Slide Presentations==

Revision as of 22:12, 2 June 2009

FDG-PET/CT Technical Committee Page

Mission; Foster adoption of ...

  • pragmatic and cost effective standards for
  • accurate and reproducible
  • longitudinal
  • quantitation of
  • biologic parameters
  • with clinical relevance
  • and known sigma

FDG-PET/CT SubCommittees


Reference Materials

  • The Netherlands Standardization Protocol for Quantitative FDG-PET in Multi-center Trials (English translation of Version 1)

Please keep the following in mind:

The development of this protocol was started about 4 years ago (2005) and approved more than 1 year ago in The Netherlands (NL). However, with gained insight, changed are scheduled to be incorporated in the next version by 2010. The following changes will be made (consider them being applied already or underway):

1. Use of oral contrast is now excluded but will be allowed in the next version 2. We are currently working on standards for CT as well, including GL for doing CT-QC (in cooperation with the radiologists/radiology societies in NL) 3. There will be an upper limit for dosage 4. We are working on traceable/calibrated and mutually linked sources for both PET and the dose calibrator and these will be used for absolute (rather than cross-) calibration (but in addition to the cross-calibration using FDG). 5. Various other minor edits/typos/changes

NB The protocol is not a step-by-step description of the logistics for doing a PET/CT study. However, it has been set up in a somewhat chronological order and may thus be used to populate (copy-paste) such a step-by-step description. Additional work required ... FDG-PET/CT Technical Committee input is highly appreciated.

Kindly submitted by Ronald Boellaard, PhD

Slide Presentations

Call Summaries

Retrieved from "https://qibawiki.rsna.org/index.php?title=FDG-PET_Biomarker_Ctte&oldid=1183"